关注
Benjamin D. Powers
Benjamin D. Powers
University of Maryland School of Medicine
在 som.umaryland.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
MotPS is the stator‐force generator for motility of alkaliphilic Bacillus, and its homologue is a second functional Mot in Bacillus subtilis
M Ito, DB Hicks, TM Henkin, AA Guffanti, BD Powers, L Zvi, K Uematsu, ...
Molecular microbiology 53 (4), 1035-1049, 2004
1252004
Examining rectal carcinoids in the era of screening colonoscopy: a surveillance, epidemiology, and end results analysis
S Taghavi, SN Jayarajan, BD Powers, A Davey, AI Willis
Diseases of the colon & rectum 56 (8), 952-959, 2013
682013
Frailty predicts morbidity and mortality after laparoscopic cholecystectomy for acute cholecystitis: an ACS-NSQIP cohort analysis
AM Fagenson, BD Powers, KA Zorbas, S Karhadkar, A Karachristos, ...
Journal of Gastrointestinal Surgery 25 (4), 932-940, 2021
422021
Completion of adjuvant therapy in patients with resected pancreatic cancer
DK DePeralta, T Ogami, JM Zhou, MJ Schell, BD Powers, PJ Hodul, ...
Hpb 22 (2), 241-248, 2020
392020
Challenges in the treatment of angiosarcoma: a single institution experience
S Singla, P Papavasiliou, B Powers, J Gaughan, M von Mehren, ...
The American Journal of Surgery 208 (2), 254-259, 2014
392014
The impact of socioeconomic deprivation on clinical outcomes for pancreatic adenocarcinoma at a high-volume cancer center: a retrospective cohort analysis
BD Powers, W Fulp, A Dhahri, DK DePeralta, T Ogami, L Rothermel, ...
Annals of surgery 274 (6), e564-e573, 2021
372021
An Intergenic Stem-Loop Mutation in the Bacillus subtilis ccpA-motPS Operon Increases motPS Transcription and the MotPS Contribution to Motility
N Terahara, M Fujisawa, B Powers, TM Henkin, TA Krulwich, M Ito
Journal of bacteriology 188 (7), 2701-2705, 2006
332006
Trends and characteristics of potentially preventable emergency department visits among patients with cancer in the US
AA Tabriz, K Turner, YR Hong, S Gheytasvand, BD Powers, JE Lafata
JAMA Network Open 6 (1), e2250423-e2250423, 2023
322023
Impact of neoadjuvant chemotherapy on the outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a multi …
EW Beal, LP Suarez-Kelly, CW Kimbrough, FM Johnston, J Greer, ...
Journal of clinical medicine 9 (3), 748, 2020
322020
Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal …
DT Pointer, D Roife, BD Powers, G Murimwa, S Elessawy, ZJ Thompson, ...
BMC cancer 20, 1-11, 2020
302020
Readmissions after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a US HIPEC collaborative study
TC Lee, K Wima, JJ Sussman, SA Ahmad, JM Cloyd, A Ahmed, K Fournier, ...
Journal of Gastrointestinal Surgery 24 (1), 165-176, 2020
292020
Predictors of anastomotic failure after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: does technique matter?
JT Wiseman, C Kimbrough, EW Beal, MY Zaidi, CA Staley, T Grotz, ...
Annals of surgical oncology 27, 783-792, 2020
272020
Racial and ethnic disparities in a state‐wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed …
JB Permuth, A Clark Daly, D Jeong, JW Choi, ME Cameron, DT Chen, ...
Cancer medicine 8 (6), 3314-3324, 2019
262019
A survival analysis of patients with localized, asymptomatic pancreatic neuroendocrine tumors: no surgical survival benefit when examining appropriately selected outcomes
BD Powers, LD Rothermel, JB Fleming, JR Strosberg, DA Anaya
Journal of Gastrointestinal Surgery 24, 2773-2779, 2020
232020
A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies
JT Wiseman, S Abdel-Misih, EW Beal, MY Zaidi, CA Staley, T Grotz, ...
Surgical oncology 37, 101492, 2021
182021
Development and validation of an explainable machine learning model for major complications after cytoreductive surgery
H Deng, Z Eftekhari, C Carlin, J Veerapong, KF Fournier, FM Johnston, ...
JAMA Network Open 5 (5), e2212930-e2212930, 2022
172022
Implications of postoperative complications for survival after cytoreductive surgery and HIPEC: a multi-institutional analysis of the US HIPEC collaborative
AC Gamboa, RM Lee, MK Turgeon, MY Zaidi, CW Kimbrough, TE Grotz, ...
Annals of surgical oncology 27, 4980-4995, 2020
162020
What is the optimal preoperative imaging modality for assessing peritoneal cancer index? An analysis from the United States HIPEC collaborative
RM Lee, MY Zaidi, AC Gamboa, S Speegle, CW Kimbrough, JM Cloyd, ...
Clinical colorectal cancer 19 (1), e1-e7, 2020
162020
The intersection of age and tumor biology with postoperative outcomes in patients after cytoreductive surgery and HIPEC
MK Turgeon, AC Gamboa, RM Lee, MY Zaidi, C Kimbrough, T Grotz, ...
Annals of surgical oncology 27, 4894-4907, 2020
152020
Optimal surveillance frequency after CRS/HIPEC for appendiceal and colorectal neoplasms: a multi-institutional analysis of the US HIPEC collaborative
AC Gamboa, MY Zaidi, RM Lee, S Speegle, JM Switchenko, J Lipscomb, ...
Annals of surgical oncology 27, 134-146, 2020
152020
系统目前无法执行此操作,请稍后再试。
文章 1–20